(Updated - December 17, 2024 6:13 AM EST)

BofA Securities analyst Jason Gerberry downgraded Exelixis (NASDAQ: EXEL) from Buy ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE